Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sims, E. J.
Right arrow Articles by Mehta, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sims, E. J.
Right arrow Articles by Mehta, A.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 28:1581-1587, 2005
© 2005 by the American Diabetes Association, Inc.


Epidemiology/Health Services/Psychosocial Research
Original Article

Decreased Lung Function in Female but not Male Subjects With Established Cystic Fibrosis–Related Diabetes

Erika J. Sims, PHD, Michael W. Green, PHD and Anil Mehta, FRCP*

From the Division of Maternal and Child Health Sciences, Ninewells Hospital and Medical School, University of Dundee, Dundee, Scotland

Address correspondence and reprint requests to Erika J. Sims, PhD, U.K. Cystic Fibrosis Database, Division of Maternal and Child Health Sciences, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY U.K. E-mail: e.j.sims{at}dundee.ac.uk

OBJECTIVE—Although cystic fibrosis–related diabetes (CFRD) is associated with decreased lung function, sex is not known to influence CFRD. However, compared with male subjects with cystic fibrosis, female subjects with cystic fibrosis have increased morbidity. This study examines the association between female subjects with CFRD and poor lung function relative to male subjects using the percent predicted forced expiratory volume in 1 s (FEV1) as a surrogate measure of morbidity.

RESEARCH DESIGN AND METHODS—We compared 323 patients with established CFRD with 489 cystic fibrosis control subjects with normal glucose tolerance (NGT) listed in the U.K. Cystic Fibrosis Database. Patients stratified by sex and chronic Pseudomonas aeruginosa infection were compared using binary logistic regression, and patients with new CFRD diagnoses were compared prospectively for the year 2002.

RESULTS—CFRD in female subjects (but not male subjects) without chronic P. aeruginosa infection had a 20% lower percent predicted FEV1 compared with control subjects with NGT (95% CI –11.7 to –27.7; P < 0.0001). Genotype, age, treatment center, age at diagnosis of cystic fibrosis, pregnancy, liver function, or dose of pancreatic enzyme replacement therapy did not confound this female disadvantage. Comparison of female subjects with newly diagnosed CFRD free of chronic P. aeruginosa infection with matched control subjects with NGT showed no FEV1 disadvantage in the 1st year after CFRD diagnosis.

CONCLUSIONS—Only female subjects with CFRD have significantly decreased lung function compared with sex-matched NGT control subjects. The absence of poor lung function in the first 12 months after diagnosis of diabetes suggests that an opportunity may exist to intervene and possibly prevent a decline in lung function, which can be as much as 20% in female subjects with CFRD.

Abbreviations: BLR, binary logistic regression • CFRD, cystic fibrosis–related diabetes • FEV1, forced expiratory volume in 1 s • FVC, forced vital capacity • GTT, glucose tolerance test • NGT, normal glucose tolerance • UKCFD, U.K. Cystic Fibrosis Database


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Diabetes CareHome page
A. I. Adler, B. S.F. Shine, P. Chamnan, C. S. Haworth, and D. Bilton
Genetic Determinants and Epidemiology of Cystic Fibrosis-Related Diabetes: Results from a British cohort of children and adults
Diabetes Care, September 1, 2008; 31(9): 1789 - 1794.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
E. J. Sims, A. Clark, J. McCormick, G. Mehta, G. Connett, A. Mehta, and on behalf of the United Kingdom Cystic Fibrosis Da
Cystic Fibrosis Diagnosed After 2 Months of Age Leads to Worse Outcomes and Requires More Therapy
Pediatrics, January 1, 2007; 119(1): 19 - 28.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
M. Creus, W. Vogel, and H. Zoller
Of Genes and Men: The Alternative View of Sex Differences in Cystic Fibrosis: Response to Sims et al. and Milla et al.
Diabetes Care, January 1, 2006; 29(1): 179 - 180.
[Full Text] [PDF]


Home page
Diabetes CareHome page
E. J. Sims, J. McCormick, and A. Mehta
Of Genes and Men: The Alternative View of Sex Differences in Cystic Fibrosis: Response to Creus et al.
Diabetes Care, January 1, 2006; 29(1): 180 - 181.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.